63 related articles for article (PubMed ID: 29414147)
1. Clobenpropit, a histamine H
Mena-Avila E; Márquez-Gómez R; Aquino-Miranda G; Nieto-Alamilla G; Arias-Montaño JA
Pharmacol Rep; 2018 Feb; 70(1):146-155. PubMed ID: 29414147
[TBL] [Abstract][Full Text] [Related]
2. Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices.
Arias-Montaño JA; Floran B; Garcia M; Aceves J; Young JM
Br J Pharmacol; 2001 May; 133(1):165-71. PubMed ID: 11325806
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes.
Harper EA; Shankley NP; Black JW
Br J Pharmacol; 1999 Oct; 128(4):881-90. PubMed ID: 10556922
[TBL] [Abstract][Full Text] [Related]
4. Histamine H3-receptor agonists and imidazole-based H3-receptor antagonists can be thermodynamically discriminated.
Harper EA; Black JW
Br J Pharmacol; 2007 Jun; 151(4):504-17. PubMed ID: 17401438
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Steroid-Based Histamine H
Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Barabás J; Béni Z; Varga B; Balázs O; Román V; Fodor L; Szikra J; Vastag M; Lévay G; Schmidt É; Lendvai B; Greiner I; Kiss B; Némethy Z; Mahó S
J Med Chem; 2024 Mar; 67(5):3643-3667. PubMed ID: 38393759
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter.
Aggarwal S; Liu X; Rice C; Menell P; Clark PJ; Paparoidamis N; Xiao YC; Salvino JM; Fontana ACK; España RA; Kortagere S; Mortensen OV
ACS Chem Neurosci; 2019 Aug; 10(8):3718-3730. PubMed ID: 31184115
[TBL] [Abstract][Full Text] [Related]
7. Structure Modeling of the Norepinephrine Transporter.
Góral I; Łątka K; Bajda M
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936154
[TBL] [Abstract][Full Text] [Related]
8. Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury.
Buzoianu AD; Sharma A; Muresanu DF; Feng L; Huang H; Chen L; Tian ZR; Nozari A; Lafuente JV; Sjöqvist PO; Wiklund L; Sharma HS
Int Rev Neurobiol; 2023; 172():37-77. PubMed ID: 37833018
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.
Yoshimoto R; Miyamoto Y; Shimamura K; Ishihara A; Takahashi K; Kotani H; Chen AS; Chen HY; Macneil DJ; Kanatani A; Tokita S
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13866-71. PubMed ID: 16954192
[TBL] [Abstract][Full Text] [Related]
10. Transporters involved in adult rat cortical astrocyte dopamine uptake: Kinetics, expression and pharmacological modulation.
Sočan V; Dolinar K; Kržan M
Eur J Neurosci; 2024 Mar; 59(6):1296-1310. PubMed ID: 38054361
[TBL] [Abstract][Full Text] [Related]
11. Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.
Brown DP; Rogers DT; Pomerleau F; Siripurapu KB; Kulshrestha M; Gerhardt GA; Littleton JM
Fitoterapia; 2016 Jun; 111():109-23. PubMed ID: 27105955
[TBL] [Abstract][Full Text] [Related]
12. The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes.
Purushotham M; Sheri A; Pham-Huu DP; Madras BK; Janowsky A; Meltzer PC
Bioorg Med Chem Lett; 2011 Jan; 21(1):48-51. PubMed ID: 21146984
[TBL] [Abstract][Full Text] [Related]
13. Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors.
Kulkarni SS; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem; 2006 Jun; 14(11):3625-34. PubMed ID: 16460947
[TBL] [Abstract][Full Text] [Related]
14. Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.
Tosh DK; Janowsky A; Eshleman AJ; Warnick E; Gao ZG; Chen Z; Gizewski E; Auchampach JA; Salvemini D; Jacobson KA
J Med Chem; 2017 Apr; 60(7):3109-3123. PubMed ID: 28319392
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of ligand recognition and design of antihistamines targeting histamine H
Xia R; Shi S; Xu Z; Vischer HF; Windhorst AD; Qian Y; Duan Y; Liang J; Chen K; Zhang A; Guo C; Leurs R; He Y
Nat Commun; 2024 Mar; 15(1):2493. PubMed ID: 38509098
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H
Reiner D; Seifert L; Deck C; Schüle R; Jung M; Stark H
Sci Rep; 2020 Aug; 10(1):13558. PubMed ID: 32782417
[TBL] [Abstract][Full Text] [Related]
17. Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters.
Ahn H; Park K; Kim D; Chi SG; Choi KH; Han SJ; Song C
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893219
[TBL] [Abstract][Full Text] [Related]
18. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.
Penmatsa A; Wang KH; Gouaux E
Nat Struct Mol Biol; 2015 Jun; 22(6):506-508. PubMed ID: 25961798
[TBL] [Abstract][Full Text] [Related]
19. Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues.
Sakloth F; Kolanos R; Mosier PD; Bonano JS; Banks ML; Partilla JS; Baumann MH; Negus SS; Glennon RA
Br J Pharmacol; 2015 May; 172(9):2210-8. PubMed ID: 25522019
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.
Fentress HM; Klar R; Krueger JJ; Sabb T; Redmon SN; Wallace NM; Shirey-Rice JK; Hahn MK
Genes Brain Behav; 2013 Nov; 12(8):749-59. PubMed ID: 24102798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
